Insider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Sells 14,375 Shares of Stock

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) insider Dana Pizzuti sold 14,375 shares of the business’s stock in a transaction that occurred on Wednesday, January 3rd. The shares were sold at an average price of $35.00, for a total value of $503,125.00. Following the sale, the insider now owns 5,911 shares in the company, […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,United States ,American ,Robertw Baird ,Dana Pizzuti ,Crinetics Pharmaceuticals Stock Down ,Crinetics Pharmaceuticals Inc ,Vanguard Group Inc ,Institutional Trading Of Crinetics Pharmaceuticals ,Crinetics Pharmaceuticals ,Jpmorgan Chase Co ,Quarter For Crinetics Pharmaceuticals ,News Ratings For Crinetics Pharmaceuticals Daily ,Securities Exchange Commission ,Wellington Management Group ,Nasdaq ,Citigroup Inc ,Jefferies Financial Group ,American Century Companies Inc ,Get Free Report ,Exchange Commission ,Pharmaceuticals Stock Down ,Financial Group ,Bay Capital Management ,Management Group ,American Century Companies ,Century Companies ,Crinetics Pharmaceuticals Daily ,Nasdaq Crnx ,Crnx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,